Hoffman Reid's Form 4 filing
Vor Biopharma Inc. (VOR) · filed Oct 8, 2025
- Accession no.
- 0002050755-25-000011
- Filed
- Oct 8, 2025, 5:20 PM ET
- Trade date
- Oct 6-7, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions. Open-market sales total $3.55M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoffman ReidCIK 0001519339 | 10% Owner |
| Reprogrammed Interchange LLCCIK 0002050755 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | Common Stock | SSaleDisposed | −17,760 | $36.00F1 | −$639,391.97 | 1,579,548 | Direct | |
| Oct 6, 2025 | Common Stock | SSaleDisposed | −34,847 | $37.12F3 | −$1,293,565.94 | 1,544,701 | Direct | |
| Oct 6, 2025 | Common Stock | SSaleDisposed | −18,156 | $37.77F4 | −$685,830.19 | 1,526,545 | Direct | |
| Oct 7, 2025 | Common Stock | SSaleDisposed | −27,624 | $33.84F5 | −$934,710.53 | 1,498,921 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $35.59 to $36.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $36.59 to $37.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $37.59 to $38.18 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $33.70 to $34.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Referenced by the price of 1 transaction in Table I.